Literature DB >> 6877173

Viral antibodies in maternal and cord sera.

T Gotlieb-Stematsky, I Meron, M Modan, Y Sayar, S Leventon-Kriss, A Fogel, R Gurewitz, V Insler.   

Abstract

Viral antibodies were determined in paired maternal and cord blood sera of 258 consecutive deliveries. Antibodies to Epstein-Barr virus (EBV), cytomegalovirus (CMV), herpes simplex type 1 (HSV-1), adenovirus (ADV), and varicella zoster (VZV) were tested by indirect immunofluorescence and to rubella (RUB) by hemagglutination inhibition. Analysis of the overall pattern of differences between maternal and cord blood showed a highly significant difference for all six viruses. Analysis regarding individual viruses showed significantly higher titers to CMV and RUB in cord blood, a higher titer to VZV in maternal blood, and similar levels of antibodies to EBV, HSV-1, and ADV in maternal and cord blood. Infants with one or more risk indicators (weight less than 3 kg, Apgar score less than or equal to 7, clinical jaundice, meconium-stained amniotic fluid, respiratory distress syndrome) were defined as "at risk." Infants free of such indicators were defined as "normal." Significantly lower antibody levels to all six viruses were found in both maternal and cord blood of the "at risk" as compared to the "normal" group, while the ratios between the maternal and cord blood levels remained similar. Birth defects were found to have no effect on antibody titers. These results indicate an efficient and selective transfer through the placenta of certain viral antibodies and the possible association of lower antibody production with the presence of risk indicators in the infants.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6877173     DOI: 10.1007/bf02123679

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  20 in total

Review 1.  Virus infections (other than rubella) during pregnancy.

Authors:  A P Waterson
Journal:  Br Med J       Date:  1979-09-08

2.  Antibodies to Epstein-Barr virus in patients with Hodgkin's disease and leukemia.

Authors:  T Gotlieb-Stematsky; A Vonsover; B Ramot; R Zaizov; U Nordan; E Aghal; G Kende; M Modan
Journal:  Cancer       Date:  1975-11       Impact factor: 6.860

3.  Simultaneous determination of antibody to Epstein-Barr virus in prenatal mothers and new-born infants.

Authors:  I Miyoshi; H Hasegawa; T Tsubota; K Hiraki
Journal:  Experientia       Date:  1972-02-15

4.  Epstein-Barr virus in infancy.

Authors:  L R Shapiro; Y Hirshaut; D M Kanef; P Glade
Journal:  J Pediatr       Date:  1972-06       Impact factor: 4.406

5.  Infection and persistence of varicella-zoster virus in lymphoblastoid Raji cell line.

Authors:  S Leventon-Kriss; T Gotlieb-Stematsky; A Vonsover; Z Smetana
Journal:  Med Microbiol Immunol       Date:  1979       Impact factor: 3.402

6.  Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport.

Authors:  P F Kohler; R S Farr
Journal:  Nature       Date:  1966-06-04       Impact factor: 49.962

7.  Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization.

Authors:  H Sato; P Albrecht; D W Reynolds; S Stagno; F A Ennis
Journal:  Am J Dis Child       Date:  1979-12

8.  The age distribution of neutralizing antibodies against varicella-zoster virus in healthy individuals.

Authors:  T Ozaki; H Nagai; T Kimura; T Ichikawa; S Suzuki; H Kito; Y Asano
Journal:  Biken J       Date:  1980-03

9.  Epstein-Barr virus infection in the neonatal period and in childhood.

Authors:  J Joncas; J Boucher; M Granger-Julien; C Filion
Journal:  Can Med Assoc J       Date:  1974-01-05       Impact factor: 8.262

10.  Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life.

Authors:  A A Gershon; R Raker; S Steinberg; B Topf-Olstein; L M Drusin
Journal:  Pediatrics       Date:  1976-11       Impact factor: 7.124

View more
  6 in total

1.  Epstein-barr virus and multiple sclerosis risk in the finnish maternity cohort.

Authors:  Kassandra L Munger; Kira Hongell; Marianna Cortese; Julia Åivo; Merja Soilu-Hänninen; Heljä-Marja Surcel; Alberto Ascherio
Journal:  Ann Neurol       Date:  2019-07-03       Impact factor: 10.422

2.  Maternal mumps antibodies in a cohort of children up to the age of 1 year.

Authors:  E Leuridan; N Goeyvaerts; N Hens; V Hutse; P Van Damme
Journal:  Eur J Pediatr       Date:  2012-03-07       Impact factor: 3.183

3.  Placental transfer of maternal rubella antibodies to full-term and preterm infants.

Authors:  N Linder; L Sirota; Y Aboudy; B German; T Lifshits; B S Barnea; B Lieberman; E Mendelson; A Barzilai
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

4.  Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HIV seroconversion.

Authors:  A Schattner; N Hanuka; B Sarov; I Sarov; Z Handzel; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

5.  Changes in immunoglobulin levels related to herpes simplex virus type 1 brain infection in pregnant mice.

Authors:  Javier S Burgos; Carlos Ramirez; Anna Brachet; Juan M Alfaro; Isabel Sastre; Fernando Valdivieso
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

6.  High susceptibility to cytomegalovirus infection of pregnant women in Flanders, Belgium.

Authors:  E Leuridan; M Ieven; N Hens; P Van Damme
Journal:  Facts Views Vis Obgyn       Date:  2012
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.